The resources below are meant to provide our members with additional information, education, and other means of assistance to you, your practice, and your patient families regarding their dietary management.
When using this information, please note the following: Coding systems and reimbursement allowable rates vary by payer. Medicare Part B uses HCPCS (Healthcare Common Procedure Coding System) to group products. Medicaid systems vary by state; some use HCPCS while others use Product Reimbursement Codes or systems of their own. Contact your state provider for more information. Private health insurance and managed care companies may use HCPCS, Product Reimbursement Codes, or their own system. Contact your provider for more information.
This special edition of the Pediatric Perspectives Newsletter includes reimbursement information.
This clinical study shows the addition of LGG helps manage infants with CMPA.
See how after 12 months of consuming Nutramigen LGG, 81 percent of the babies with CMPA in this study built tolerance to cow’s milk protein.
Formula with LGG for management CMPA in infants influences tolerance, per this independent multicenter study.
A study to compare the effect on growth in healthy infants of a new amino acid–based formula (AAF) and a control extensively hydrolyzed formula (EHF), with both docosahexaenoic acid (DHA) and arachidonic acid (ARA) at levels similar to those in human milk worldwide. In study 2, to evaluate the hypoallergenicity of this new AAF in infants and children with confirmed cow’s milk allergy (CMA).
DHA is proven to improve sustained attention in infants.
AAP Reflux Management Guidance - Gastroesophageal Reflux: Management Guidance for the Pediatrician, from the American Academy of Pediatrics
A study to evaluate a pre-thickened formula (Enfamil A.R.) for regurgitant gastroesophageal refllux, 104 infants were enrolled in a 5-week, multicenter, double-blind, randomized, placebo-controlled parallel group trial.